Alzamend Neuro, Inc. Share Price & Technical Analysis
ALZN · $1.15 (+1.77%)
Healthcare / Biotechnology
$1.15
+1.77%
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neuro…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -10% avg return in past 3 year May month.
-28% return in 2026, -174% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 22% | -5% | -45% | 0% | 0% | – | – | – | – | – | – | – | -28% |
| 25 | -3% | -27% | 18% | -31% | -37% | -26% | -24% | 14% | -4% | 4% | -12% | -18% | -145% |
| 24 | -7% | 2% | 6% | -28% | -23% | -37% | -9% | -36% | -28% | -8% | -18% | -13% | -199% |
| 23 | 16% | -22% | -21% | 24% | 30% | -30% | -8% | -43% | -17% | -49% | -30% | -26% | -177% |
| 22 | -20% | -21% | 3% | -16% | -7% | -12% | 3% | 2% | 30% | -3% | -4% | -52% | -98% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.96M
P/E ratio
—
52W high
$8.22
52W low
$0.84
Volume
45,614
Beta
0.11
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Alzamend Neuro, Inc. share price today?
- Alzamend Neuro, Inc. (ALZN) last traded around $1.15 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ALZN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ALZN. Download the app for real-time alerts.
- How can I analyze Alzamend Neuro, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.